Current Drug Abuse Reviews
Title:Editorial: Mobile Technology and Naturalistic Study Designs in Addiction Research
Volume: 5 Issue: 3
Author(s): Joris C. Verster, Brian Tiplady and Adele McKinney
Affiliation:
Export Options
About this article
Cite this article as:
C. Verster Joris, Tiplady Brian and McKinney Adele, Editorial: Mobile Technology and Naturalistic Study Designs in Addiction Research, Current Drug Abuse Reviews 2012; 5 (3) . https://dx.doi.org/10.2174/1874473711205030169
DOI https://dx.doi.org/10.2174/1874473711205030169 |
Print ISSN 1874-4737 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4745 |
24
Related Articles
-
Benefits of Resistance Training in Older Adults
Current Aging Science Endoplasmic Reticulum Stress and Bipolar Disorder - Almost Forgotten Therapeutic Drug Targets in the Unfolded Protein Response Pathway Revisited
CNS & Neurological Disorders - Drug Targets The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress
Current Neuropharmacology Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging
Current Aging Science Cognitive Behavioral Therapy in Prodromal Psychosis
Current Pharmaceutical Design Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis
CNS & Neurological Disorders - Drug Targets Determination of Body Mass Index and Physical Activity in Normal Weight Children and Evaluation of Salivary Levels of Interleukin 10 and Interleukin 17
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Intravenous Immunoglobulin Treatment Preserves and Protects Primary Rat Hippocampal Neurons and Primary Human Brain Cultures Against Oxidative Insults
Current Alzheimer Research Role of the Region 23-28 in Aβ Fibril Formation: Insights from Simulations of the Monomers and Dimers of Alzheimers Peptides Aβ40 and Aβ42
Current Alzheimer Research Momordica balsamina: A Medicinal and Neutraceutical Plant for Health Care Management
Current Pharmaceutical Biotechnology Editorial [Hot Topic: Serotonin Receptors as Targets in Drug Discovery and Medicinal Chemistry (Guest Editor: Dr. Marcello Leopoldo)]
Current Topics in Medicinal Chemistry Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System
Current Pharmaceutical Design Brain-derived Neurotrophic Factor Promotes Growth of Neurons and Neural Stem Cells Possibly by Triggering the Phosphoinositide 3-Kinase/ AKT/Glycogen Synthase Kinase-3β/β-catenin Pathway
CNS & Neurological Disorders - Drug Targets Neurochemical Substrates of MDMA Reward: Effects of the Inhibition of Serotonin Reuptake on the Acquisition and Reinstatement of MDMA-induced CPP
Current Pharmaceutical Design Effect of the Antifibrillatory Compound Tedisamil (KC-8857) on Transmembrane Currents in Mammalian Ventricular Myocytes
Current Medicinal Chemistry Evaluation of Time-Dependent Cytochrome P450 Inhibition in a High-Throughput, Automated Assay: Introducing a Novel Area Under the Curve Shift Approach
Drug Metabolism Letters Glucocorticoids, the Etiology of Obesity and the Metabolic Syndrome
Current Alzheimer Research Patent Review
Combinatorial Chemistry & High Throughput Screening Signaling Pathways Involved in Leukocyte Adhesiveness and Migration during Inflammation: Potential Targets for Therapeutic Interventions?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Attention Deficit Hyperactive Disorder and Occurrence of Tic Disorders in Children and Adolescents—What is the Verdict
Current Pediatric Reviews